ABBV-105, a selective and irreversible inhibitor of...

  • Main
  • 2018 / 06
  • ABBV-105, a selective and irreversible inhibitor of...

ABBV-105, a selective and irreversible inhibitor of Bruton’s Tyrosine Kinase (BTK), is efficacious in multiple preclinical models of inflammation

Goess, Christian, Harris, Christopher M., Murdock, Sara, McCarthy, Richard W., Sampson, Erik, Twomey, Rachel, Mathieu, Suzanne, Mario, Regina, Perham, Matthew, Goedken, Eric R., Long, Andrew J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Modern Rheumatology
DOI:
10.1080/14397595.2018.1484269
Date:
June, 2018
File:
PDF, 1.49 MB
english, 2018
Conversion to is in progress
Conversion to is failed